Maverick Capital’s Tandem Diabetes Care TNDM Stock Holding History

Maverick Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,615	Closed	-$634K	–	541
2023 Q1	$634K	Buy	+15,615	New	+$646K	0.02%	205
2022 Q1	–	Sell	-721	Closed	-$109K	–	372
2021 Q4	$109K	Sell	721 -6,599	-90%	-$891K	﹤0.01%	190
2021 Q3	$874K	Buy	+7,320	New	+$807K	0.01%	343

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Maverick Capital's TNDM Position: Q2 2023 in Review

Maverick Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 15,615 shares — an estimated $634K sold.

Maverick Capital first reported a position in TNDM in Q3 2021 and held it in 3 quarters. The position peaked at $874K in Q3 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Maverick Capital reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Maverick Capital sold 15,615 Tandem Diabetes Care shares in Q2 2023, an estimated $634K.
Maverick Capital first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 3 quarters.
Maverick Capital's Tandem Diabetes Care position peaked at $874K in Q3 2021.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Maverick Capital's 13F filing for Q2 2023, filed 14 Aug 2023.